Edward J. JR Benz
CIK 1691160 · last filed 2026-06-24
Edward J. JR Benz is a corporate insider who has filed 17 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for CADL, was dated Jun 24, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
17
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CADL | Director | — | $10.65 | — | $0 | 5 | 2026-06-24 |
| Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Director | — | $25.59 | — | $0 | 8 | 2024-06-11 |
| Renovacor, Inc. (RCOR.WS) Delisted | Director | — | $0.07 | — | $0 | 2 | 2022-05-27 |
| XBIO | Director | — | $3.22 | — | $0 | 1 | 2016-12-23 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-24 | CADL | Grant (A) | — | $0 | EDGAR |
| 2025-06-18 | CADL | Grant (A) | — | $0 | EDGAR |
| 2024-06-27 | CADL | Grant (A) | — | $0 | EDGAR |
| 2024-06-11 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-06-29 | CADL | Grant (A) | — | $0 | EDGAR |
| 2023-06-23 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-05 | — | Mixed | — | $0 | |
| 2022-10-17 | CADL | Grant (A) | — | $0 | EDGAR |
| 2022-06-24 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | Renovacor, Inc. (RCOR.WS) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.